Regulatory and market intelligence for the e-cigarette sector
Regulatory briefing / Sweden
This page covers all of our Swedish regulatory news briefings and industry updates. These range from changes and developments in vaping legislation and restrictions to new proposals and policy developments. The section also offers industry updates on legal battles, e-cigarette tax changes, ban proposals, lobby updates, etc.
A new report commissioned by the Swedish government suggests stricter regulation of tobacco-alternative products, including a blanket ban on all flavoured e-cigarettes and tighter rules on marketing and advertising
World No Tobacco Day provides an opportunity to consider the approach that public health authorities, policymakers, and advocates around the world have towards the role of tobacco-alternatives products
E-liquids with nicotine concentration over 17 mg/ml are now subject to a de facto ban in Sweden. Although they are not illegal, permits are required for their sale and use, as a recently-published ECigIntelligence report reveals.
Sweden is to join its Scandinavian neighbours Finland and Denmark in adding vaping to its ban on smoking in a variety of public places. The country is also preparing to tax e-liquids, with or without nicotine
Sweden is set to bring in a new tax on e-cigarettes, following a proposal in the national budget for 2018. The exact nature and level of the tax will be determined after consultation with relevant bodies
Sweden, one of the last five countries to transpose Article 20 of the European Union’s Tobacco Products Directive (TPD), has announced draft legislation to bring the country into line with the rest of the EU on e-cigarettes
Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus products classified as modified risk – and they mix outright rejections with some very mild encouragement.
A Swedish court has upheld attempts by the country’s medical products regulator to treat nicotine-containing e-cigarettes as pharmaceuticals, meaning that they must go through a licensing process and cannot be sold in outlets such as groceries and convenience stores.